Key Points: Merck is accused of buying up Indian companies that produce ivermectin to shut down their operations. Big Pharma is against the widespread availability and affordability of ivermectin because it is cutting into their profit streams for other drugs. Dr. Kazuhiro Nagao, Chairman of the medical company Yuwakai and Director of the Nagao Amagasaki
This post was created with our nice and easy submission form. Create your post!